Retigabine attenuates focal cerebral ischemic injury through inhibiting mitochondria-dependent apoptotic pathway
1Department of Pathology, Changchun Medical College, Changchun, China. zrensheng@sina.com.
Objective:
We explored the protective effect of retigabine (RTG) on focal cerebral ischemic injury and the potential molecular mechanism.
Materials And Methods:
A mouse model of middle cerebral artery occlusion (MCAO) was established to induce cerebral ischemic injury. Blood samples were collected for the measurement of malondialdehyde (MDA), superoxide dismutase (SOD) and reduced glutathione (GSH). The brain infarct volume was stained by triphenyltetrazolium chloride. The cell apoptosis was observed by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) staining. The expression of B-cell lymphoma-2 (Bcl-2), BCL2-Associated X (Bax), cleaved caspase 3, p-p38 and p-JNK, were determined by Western blot.
Results:
RTG treatment reduced the MCAO-induced increase in brain infarct volume and neurological deficit scores. RTG treatment reduced the level of MDA and increased the activity of SOD and GSH. RTG treatment also decreased the Bax/Bcl-2 ratio and cleaved caspase 3 expression in the ischemic tissues. Further, RTG treatment decreased the phosphorylation levels of p38 and JNK in the ischemic tissues.
Conclusions:
RTG attenuated cerebral ischemic injury through reducing oxidative stress and mitochondria-mediated apoptosis via inhibiting p38 and JNK phosphorylation.
Insights
Retigabine (RTG) protects against stroke by reducing oxidative stress and cell death. This neuroprotective effect is mediated by inhibiting key inflammatory signaling pathways, offering a potential therapeutic strategy for ischemic injury.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Focal cerebral ischemic injury, often caused by middle cerebral artery occlusion (MCAO), leads to significant neuronal damage.
- Oxidative stress and apoptosis are key pathological mechanisms in ischemic stroke.
- Identifying neuroprotective agents is crucial for stroke treatment.
Purpose of the Study:
- To investigate the neuroprotective effects of retigabine (RTG) on focal cerebral ischemic injury.
- To elucidate the underlying molecular mechanisms of RTG's protective action.
Main Methods:
- A mouse model of MCAO was used to induce ischemic injury.
- Biochemical markers of oxidative stress (MDA, SOD, GSH) were measured.
- Brain infarct volume, apoptosis (TUNEL), and protein expression (Bcl-2, Bax, caspase 3, p38, JNK) were assessed.
Main Results:
- RTG treatment significantly reduced brain infarct volume and neurological deficits.
- RTG decreased malondialdehyde (MDA) levels and increased superoxide dismutase (SOD) and reduced glutathione (GSH) activity.
- RTG inhibited apoptosis by reducing the Bax/Bcl-2 ratio and cleaved caspase 3 expression, and decreased p38 and JNK phosphorylation.
Conclusions:
- Retigabine (RTG) demonstrates significant neuroprotective effects against focal cerebral ischemic injury.
- RTG attenuates ischemic injury by mitigating oxidative stress and inhibiting mitochondria-mediated apoptosis.
- The mechanism involves the suppression of p38 and JNK phosphorylation pathways.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
cAMP-dependent Protein Kinase Pathways
Feedback Inhibition
Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...


